IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

Research output: Contribution to journalPublished meeting abstract

Details

Authors
  • Olav Dalgard
  • Hans Verbaan
  • Helmer Ring-Larsen
  • Kristian Bjoro
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Gastroenterology and Hepatology
Original languageEnglish
Pages (from-to)1875
JournalHepatology
Volume48
Issue number4
Publication statusPublished - 2008
Publication categoryResearch
Peer-reviewedYes
Event59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases - San Francisco, CA
Duration: 2008 Oct 312008 Nov 4

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)